07:00 , Jul 1, 2002 |  BioCentury  |  Finance

Ebb & Flow

The first regulatory setback isn't the knockout punch for Oxford GlycoSciences (LSE:OGS; OGSI), which fell 92.5p (24%) to 300p on Monday after receiving a non-approvable letter from the FDA for its Vevesca ( OGT 918...
07:00 , Jun 27, 2002 |  BC Extra  |  Financial News

Meristem raises EUR21 million

Meristem (Clermont-Ferrand, France) raised EUR21 million ($20.5 million) in its third private round. New investors included AGF Private Equity; Antin Innovation; CPR Private Equity; Innoven Partenaires; La Compagnie Financire de Rothschild; Odysse Venture; Pechel Industries;...